A Lack Of Data Keeps Propoxyphene On The Market ... For Now At Least

The lack of clear data substantiating the risk of fatal overdose with propoxyphene-containing drug products seems to have led FDA to its decision to keep the products on the market - and thus deny Public Citizen's petition for their withdrawal